NO952234L - Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft - Google Patents

Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft

Info

Publication number
NO952234L
NO952234L NO952234A NO952234A NO952234L NO 952234 L NO952234 L NO 952234L NO 952234 A NO952234 A NO 952234A NO 952234 A NO952234 A NO 952234A NO 952234 L NO952234 L NO 952234L
Authority
NO
Norway
Prior art keywords
therapy
transdermal administration
acetylsalicylic acid
antithrombosis
administration system
Prior art date
Application number
NO952234A
Other languages
English (en)
Norwegian (no)
Other versions
NO952234D0 (no
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/de
Priority claimed from PCT/EP1993/003231 external-priority patent/WO1994013302A1/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO952234L publication Critical patent/NO952234L/no
Publication of NO952234D0 publication Critical patent/NO952234D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO952234A 1992-12-07 1995-06-06 Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft NO952234D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält
PCT/EP1993/003231 WO1994013302A1 (de) 1991-12-20 1993-11-18 Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe

Publications (2)

Publication Number Publication Date
NO952234L true NO952234L (no) 1995-06-06
NO952234D0 NO952234D0 (no) 1995-06-06

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952234A NO952234D0 (no) 1992-12-07 1995-06-06 Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft

Country Status (14)

Country Link
EP (1) EP0671916A1 (fi)
JP (1) JP3799502B2 (fi)
AU (1) AU694410B2 (fi)
CA (1) CA2150033A1 (fi)
CZ (1) CZ149495A3 (fi)
FI (1) FI120719B (fi)
HR (1) HRP931474A2 (fi)
HU (1) HUT75680A (fi)
IL (1) IL107867A (fi)
NO (1) NO952234D0 (fi)
NZ (1) NZ258129A (fi)
PL (1) PL174770B1 (fi)
SK (1) SK75495A3 (fi)
ZA (1) ZA939126B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1738623A (zh) * 2003-01-23 2006-02-22 夏尔控股公司 治疗血小板增多症的制剂和方法
EP1716854A4 (en) 2004-02-16 2010-01-20 Teikoku Seiyaku Kk EXTERNAL PREPARATION FOR TREATING PAINFUL SKIN WOUNDS
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
JP6720257B2 (ja) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
CA2150033A1 (en) 1994-06-23
FI952805A0 (fi) 1995-06-07
IL107867A0 (en) 1994-04-12
AU5563294A (en) 1994-07-04
NO952234D0 (no) 1995-06-06
PL309285A1 (en) 1995-10-02
NZ258129A (en) 1999-10-28
AU694410B2 (en) 1998-07-23
HU9501641D0 (en) 1995-08-28
EP0671916A1 (de) 1995-09-20
HUT75680A (en) 1997-05-28
SK75495A3 (en) 1996-05-08
ZA939126B (en) 1994-08-05
FI952805A (fi) 1995-06-07
FI120719B (fi) 2010-02-15
PL174770B1 (pl) 1998-09-30
JP3799502B2 (ja) 2006-07-19
CZ149495A3 (en) 1996-03-13
IL107867A (en) 1998-08-16
JPH08504198A (ja) 1996-05-07
HRP931474A2 (en) 1994-12-31

Similar Documents

Publication Publication Date Title
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
CZ158695A3 (en) Pyrazolopyrimidine compounds as such and for treating diseases and pharmaceutical preparations based thereon
TW234691B (fi)
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
DK515489A (da) Dispergerbar laegemiddelformulering
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
NO990283L (no) Formulering for behandling og/eller profylakse av demens
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
GB9323403D0 (en) Pharmaceuticals
IT1263913B (it) Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono